RAS Oncogene Mutations and Outcome of Therapy for Childhood Acute Lymphoblastic Leukemia

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Childhood Acute Lymphoblastic Leukemia

Oncologist
Cancer ResearchMedicineOncology
1997English

FLT3 Mutations in Childhood Acute Lymphoblastic Leukemia at First Relapse

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Non-Infectious Chemotherapy-Associated Acute Toxicities During Childhood Acute Lymphoblastic Leukemia Therapy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Lymphomatoid Granulomatosis After Childhood Acute Lymphoblastic Leukemia: Report of Effective Therapy

Pediatrics
Child HealthPediatricsPerinatology
2001English

Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children With Acute Lymphoblastic Leukemia

Archives of Medical Research
Medicine
2016English

Genomic Characterization of Childhood Acute Lymphoblastic Leukemia

Seminars in Hematology
Hematology
2013English

Methotrexate Resistance in Relation to Treatment Outcome in Childhood Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy